F
FACIT
Venture CapitalActiveFACIT is designed to support early stage proof-of-concept (POC) studies within Ontario academic institutions.
19
Investments
5
Exits
$700M
AUM
26.3%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for FACIT.
Investment Thesis & Strategy
FACIT invests in early-stage proof-of-concept studies within Ontario academic institutions across various industries. They focus on supporting innovative research and development initiatives.
Notable Exits
CompanyTypeYearValue / Acquirer
Deep GenomicsAcquisition2024—
CyclicaAcquisition2024—
Turnstone BiologicsIPO2023—
Repare TherapeuticsIPO2020—
BlueRock TherapeuticsAcquisition2019$1B
Frequently Asked Questions
FACIT focuses on Series A, Series B, Series C+ stage investments.